News
Mayo Clinic has treated the first person in the U.S. using a novel radioactive medicine for advanced breast cancer as part of ...
Mayo Clinic treats first person in the US with a novel radiopharmaceutical therapy for breast cancer
Mayo Clinic has treated the first person in the U.S. using a novel radioactive medicine for advanced breast cancer as part of an international multisite clinical trial.
8d
Health and Me on MSNMale Birth Control Pill Clears Early Safety Trails, Scientists Test New Contraceptive Without Side Effects
A new male birth control pill has passed early safety trials, showing promise with minimal side effects. Larger human trials ...
I had a complete hysterectomy in my late 40s due to endometriosis. I am now 68 and have been on 0.1-mg patches of estradiol ...
New research is showing promise that a vaccine may be able to fight one type of the most common cancers in women. Phase one ...
Patients on Itovebi plus Ibrance and fulvestrant had improved progression-free and overall survival compared to Ibrance-fulvestrant alone.
22d
News-Medical.Net on MSNOsteoblast estrogen receptor signaling found essential for bone integrity
Estrogen plays an important role in keeping bones healthy. Now, researchers investigated how membrane-initiated estrogen receptor alpha (mERα) signaling in specific cell types of female mice affects ...
Generation Alpha’s FarmVille Is Growing Like Crazy in Roblox On Saturday, more than 16 million people were planting seeds and collecting exotic pets within Grow a Garden at the same time.
Vepdegestrant is an oral proteolysis-targeting chimera (PROTAC) estrogen receptor (ER) degrader that directly harnesses the ubiquitin–proteasome system. In this phase 3, open-label, randomized ...
Does stereotactic ablative body radiotherapy (SABR) to oligoprogressive metastases delay a change in systemic therapy in patients with estrogen receptor–positive, human epidermal growth factor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results